[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioCentury @BioCentury on x 16.3K followers
Created: 2025-07-25 20:30:12 UTC
In BioCentury's Public Equity Report: Amid a difficult stretch for IPOs, Nanjing Leads Biolabs has priced a HK$1.5B offering in Hong Kong; plus Abivax's $747.5M follow-on, Pfizer's investment in 3SBio and more
XXX engagements
Related Topics $1530hk investment $7475m kong hong kong $15b stretch for